Annual Drug Patent Expirations for IMVEXXY
Imvexxy is a drug marketed by Therapeuticsmd Inc and is included in one NDA. It is available from one supplier. There are fourteen patents protecting this drug.
Drug patent litigation for IMVEXXY.
This drug has one hundred and thirty-four patent family members in nineteen countries.
The generic ingredient in IMVEXXY is estradiol. One supplier is listed for this compound. Additional details are available on the estradiol profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
